Clinical Trials Logo

Spinal Cord Injuries clinical trials

View clinical trials related to Spinal Cord Injuries.

Filter by:

NCT ID: NCT03949699 Completed - Clinical trials for Spinal Cord Injuries

Resistance Training to Improve Strength and Functional Trunk Stability in Adults With Paraplegia

Start date: November 24, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effectiveness of an 8- week resistance training routine to improve functional trunk strength, muscle activation, and physical functioning in exercise in 30 adults with paraplegic SCI. This study will also examine outcomes of confidence in one's ability to avoid falling during balance challenges, and self-efficacy for participating in exercise activity.

NCT ID: NCT03949660 Recruiting - Neurogenic Bowel Clinical Trials

Improving Bowel Function and Quality of Life After Spinal Cord Injury

Start date: September 15, 2018
Phase: N/A
Study type: Interventional

Bowel dysfunction is consistently rated as one of the most common complications affecting daily life for individuals with spinal cord injury. The overall objective of this study is to investigate whether the use of specific spinal cord epidural stimulation will affect bowel function. This study will also examine how alterations in bowel function influence quality of life outcomes. The results of this study may aid in the development of treatments to help individuals with spinal cord injuries that have impaired bowel function.

NCT ID: NCT03945110 Completed - Clinical trials for Spinal Cord Injuries

Intravesical Glycosaminoglycan Instillation and Urinary Tract Infection in Acute Spinal Cord Injury

Start date: September 18, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and feasibility of administering glycosaminoglycan (GAG) therapy, iAluRil®, intravesically in individuals with acute spinal cord injury (SCI), commencing within the first ten days of injury, to prevent early urinary tract infections.

NCT ID: NCT03941600 Completed - Clinical trials for Spinal Cord Injuries

Feasibility of Exercise and Spinal Cord Injury

Start date: April 10, 2019
Phase: N/A
Study type: Interventional

The purpose of the study is to examine the impact of a community-based exercise intervention (CBEI) for persons with spinal cord injury (PwSCI) on physiological and psychological well-being and identify barriers and facilitators to implementation.

NCT ID: NCT03940274 Completed - Spinal Cord Injury Clinical Trials

Walk-Training Program for Individuals With Chronic Spinal Cord Injury (SCI)

Start date: December 4, 2018
Phase: N/A
Study type: Interventional

Cardiovascular disease (CVD) is the common leading cause of death among people with spinal cord injury (SCI) and occurs at an early age in people with SCI as compared to able-bodied people. The findings are consistent in demonstrating a high prevalence of CVD among people with SCI. Lack of physical activity and/or prolonged sitting which is observed in people with SCI due to impaired/loss of motor function is associated with increased risk factors of CVD. By doing this study, researchers hope to learn the effects of walking training on cardiovascular health among people with chronic SCI.

NCT ID: NCT03935724 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Stem Cells in Spinal Cord Injury

SCI2
Start date: January 18, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled and delayed-start phase II/III clinical study.

NCT ID: NCT03935321 Completed - Clinical trials for Spinal Cord Injury, Acute

NISCI - Nogo Inhibition in Spinal Cord Injury

NISCI
Start date: May 15, 2019
Phase: Phase 2
Study type: Interventional

The purpose of the NISCI trial is to test if an antibody therapy can improve movement and quality of life of tetraplegic patients. A previous trial showed this treatment is safe and well accepted. This is a placebo controlled, randomized, double blind, multicenter, multinational study to assess the safety, tolerability, feasibility and preliminary efficacy of early (within 4-28 days post injury) initiation of treatment with repeated bolus injections of NG-101 in cervical acute SCI patients. The study has 3 phases: screening/baseline Phase, treatment phase, and a follow-up phase. The study design will allow simultaneous enrolment of patients with complete or incomplete SCI. Enrolment and stratification of the patients is based and individualized prediction of upper limb outcomes. For further information please visit NISCI website: https://nisci-2020.eu

NCT ID: NCT03933072 Recruiting - Clinical trials for Spinal Cord Transection

Autologous Bulbar Olfactory Ensheathing Cells and Nerve Grafts for Treatment of Patients With Spinal Cord Transection

Start date: March 1, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this experimental therapy is to evaluate the safety and efficacy of transplantation of autologous olfactory ensheathing cells (OECs) and olfactory nerve fibroblasts (ONFs) obtained from the olfactory bulb with simultaneous reconstruction of the posttraumatic spinal cord gap with peripheral nerve grafts, in patients with chronic complete spinal cord injury. The treatment will be performed in two patients that have sustained an anatomically complete spinal cord transection between the spinal cord segments C5 and Th10. All patients wanting to participate in this study have to send their application at the address: walk-again-project.org

NCT ID: NCT03931408 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections

Start date: February 19, 2019
Phase: Phase 2
Study type: Interventional

Participants will undergo daily gentamicin bladder instillations to determine if its use will reduce the rate of symptomatic urinary tract infections (UTIs) as well as the use of oral and intravenous antibiotics in adults with chronic spinal cord injury (SCI) who have recurrent UTIs. Participants are randomized into one of three groups: 1) Gentamicin and saline instillation 2) Saline only instillation 3) Standard of care, no instillation.

NCT ID: NCT03930056 Recruiting - Spinal Cord Injury Clinical Trials

C-Brace II Spinal Cord Injury

Start date: April 16, 2019
Phase: N/A
Study type: Interventional

A randomized, repeated measures comparative design study to compare use of a micro-processor controlled knee-ankle-foot orthosis vs. traditional care knee-ankle-foot-orthosis (KAFO) models following discharge from inpatient rehabilitation.